Repertoire Immune Medicines

From immune codes to immune medicines.

Cambridge, United States · Founded 2020 · $289.0M raised

Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$289.0M
Last Round
$35.0M Venture RoundApr 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to treat cancer and autoimmune diseases. Founded in 2020 and headquartered in Cambridge, Massachusetts (with additional operations in Zurich, Switzerland), Repertoire was founded under Flagship Pioneering. The company's proprietary DECODE platform provides comprehensive insights into the immune synapse — the central hardware of the adaptive immune system — identifying T cell receptor (TCR) and antigen epitope pairs across all human HLAs. Using these discovered 'immune codes,' Repertoire designs TCR bispecific molecules, mRNA cancer vaccines, and mRNA tolerizing vaccines to program the immune system to eliminate tumors and restore immune balance in autoimmune patients. The company has established collaborations with Eli Lilly, Genentech, and Pfizer, and is advancing a pipeline of candidates in immuno-oncology and autoimmune disease indications.

Summary

Repertoire Immune Medicines is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $289.0M in total across 4 rounds, most recently a $35.0M Venture Round in Apr 2025. Investors include Flagship Pioneering, Roche and SoftBank.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundSeries C/ExtensionApr 2025
$35.0M

Sign up to see all 4 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Repertoire Immune Medicines on Indexed.vc
<a href="https://indexed.vc/companies/repertoire-immune-medicines"><img src="https://indexed.vc/api/badge/company/repertoire-immune-medicines" alt="Repertoire Immune Medicines on Indexed.vc" width="260" height="76" /></a>